Please sign in to follow a disease.
Lung sarcomatoid carcinoma
MONDO:0006279A rare, aggressive, poorly differentiated, non-small cell lung carcinoma characterized by the presence of a sarcomatoid component often associated with giant cell differentiation. There is a male to female ratio of 4:1. Clinical symptoms include cough, hemoptysis, chest pain, progressive dyspnea and fever secondary to recurrent pneumonia. Cigarette smoking is a major risk factor.
Also known as: lung sarcomatoid carcinoma, sarcomatoid carcinoma of the lung
2813 clinical trials for this condition and its sub-types, 3 tagged with Lung sarcomatoid carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Lung sarcomatoid carcinoma
-
Pulmonary blastoma 1 trial · 4 incl. sub-types
3 sub-types
- Pleuropulmonary blastoma 4 trials Sub-types →
- Classic pulmonary blastoma 0 trials
- Epithelial predominant pulmonary blastoma 0 trials
-
Lung giant cell carcinoma 1 trial
-
Lung pleomorphic carcinoma 1 trial
Most studied deeper sub-types
-
Promising combo tackles rare lung cancer in small trial
Disease control CompletedThis study tested a combination of two drugs, tislelizumab and anlotinib, in 29 people with advanced pulmonary pleomorphic carcinoma, a rare and aggressive lung cancer. The goal was to see if the combo could shrink tumors or slow the disease. Participants had stage III or IV canc…
Phase 2 • Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New combo tackles rare lung cancer
Disease control CompletedThis phase 2 trial tested a combination of the immunotherapy drug durvalumab with two chemotherapy drugs (doxorubicin and ifosfamide) in 16 people with a rare and aggressive type of lung cancer called pulmonary sarcomatoid carcinoma. The goal was to see if the combination could s…
Phase 2 • Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC